Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
2,403
Views
11
CrossRef citations to date
0
Altmetric
Articles

Patient and caregiver preferences on treatment attributes for atopic dermatitis

Claire Ervina RTI Health Solutions, Research Triangle Park, NC, USACorrespondence[email protected]
View further author information
,
Rebecca Crawforda RTI Health Solutions, Research Triangle Park, NC, USAView further author information
,
Emily Evansa RTI Health Solutions, Research Triangle Park, NC, USAView further author information
,
Steven R. Feldmanb Wake Forest Baptist Health, Winston-Salem, NC, USAORCID Iconhttps://orcid.org/0000-0002-0090-6289View further author information
ORCID Icon,
Joshua Zeichnerc Mount Sinai Hospital, New York, NY, USAView further author information
,
Michael A. Zielinskid Pfizer Inc, Collegeville, PA, USAView further author information
,
Joseph C. Cappellerie Pfizer Inc, Groton, CT, USAORCID Iconhttps://orcid.org/0000-0001-9586-0748View further author information
ORCID Icon,
Marco DiBonaventuraf Pfizer Inc, New York, NY, USAView further author information
,
Liza Takiyad Pfizer Inc, Collegeville, PA, USAView further author information
&
Daniela E. Myersd Pfizer Inc, Collegeville, PA, USAORCID Iconhttps://orcid.org/0000-0003-1426-9919View further author information
ORCID Icon show all
Pages 2225-2233 | Received 13 May 2021, Accepted 06 Jun 2021, Published online: 06 Oct 2021

References

  • Garside R, Stein K, Castelnuovo E, et al. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess. 2005;9(29):iii, xi–xiii, 1–230.
  • Baron SE, Cohen SN, Archer CB, et al. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 2012;37(Suppl. 1):7–12.
  • Al-Naqeeb J, Danner S, Fagnan LJ, et al. The burden of childhood atopic dermatitis in the primary care setting: a report from the Meta-LARC Consortium. J Am Board Fam Med. 2019;32(2):191–200.
  • Drucker AM, Wang AR, Li WQ, et al. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26–30.
  • Reed B, Blaiss MS. The burden of atopic dermatitis. Allergy Asthma Proc. 2018;39(6):406–410.
  • Simpson EL, Guttman-Yassky E, Margolis DJ, et al. Association of inadequately controlled disease and disease severity with patient-reported disease burden in adults with atopic dermatitis. JAMA Dermatol. 2018;154(8):903–912.
  • Eckert L, Gupta S, Amand C, et al. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol. 2017;77(2):274–279.e3.
  • Eckert L, Gupta S, Gadkari A, et al. Burden of illness in adults with atopic dermatitis: analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. J Am Acad Dermatol. 2019;81(1):187–195.
  • de Bruin-Weller M, Gadkari A, Auziere S, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34(5):1026–1036.
  • Girolomoni G, Luger T, Nosbaum A, et al. The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: analysis of a cross-sectional survey. Dermatol Ther (Heidelb). 2021;11(1):117–130.
  • Charman CR, Venn AJ, Ravenscroft JC, et al. Translating patient-oriented eczema measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol. 2013;169(6):1326–1332.
  • Langan SM, Thomas KS, Williams HC. What is meant by a "flare" in atopic dermatitis? A systematic review and proposal. Arch Dermatol. 2006;142(9):1190–1196.
  • Draelos ZD, Feldman SR, Berman B, et al. Tolerability of topical treatments for atopic dermatitis. Dermatol Ther (Heidelb). 2019;9(1):71–102.
  • Boguniewicz M, Fonacier L, Guttman-Yassky E, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10–22.e2.
  • National Eczema Association. Atopic dermatitis: treatments; 2017; [cited 2018 Nov 9]. Available from: https://nationaleczema.org/eczema/types-of-eczema/atopic-dermatitis/
  • Paller AS, Kabashima K, Bieber T. Therapeutic pipeline for atopic dermatitis: end of the drought? J Allergy Clin Immunol. 2017;140(3):633–643.
  • Renert-Yuval Y, Guttman-Yassky E. New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines. Ann Allergy Asthma Immunol. 2020;124(1):28–35.
  • Eichenfield LF, DiBonaventura M, Xenakis J, et al. Costs and treatment patterns among patients with atopic dermatitis using advanced therapies in the United States: analysis of a retrospective claims database. Dermatol Ther (Heidelb). 2020;10(4):791–806.
  • Heath MS, Kolli SS, Dowling JR, et al. Pharmacotherapeutic strategies for standard treatment-resistant psoriasis. Expert Opin Pharmacother. 2019;20(4):443–454.
  • Boeri M, Sutphin J, Hauber B, et al. Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment. J Dermatolog Treat. 2020;1–10.
  • Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 3rd ed. Los Angeles (CA): SAGE; 2018.
  • McClearly KK. The more than skin deep "voice of the patient" report; 2020; [cited 2020 Nov 13]. Available from: http://www.morethanskindeep-eczema.org/uploads/1/2/5/3/125377765/mtsd_report_-_digital_file_1.pdf

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.